Dr. Popa is Health Sciences associate clinical professor in the Division of Hospital Medicine at UC San Diego.
Medicine Grand Rounds will resume on Wednesday, September 4, 2013, with a presentation by Ian Jenkins, MD, Health Sciences associate clinical professor in the Division of Hospital Medicine at UC San Diego.
His presentation is titled, “America’s Cost-Quality Crisis.”
Jenkins holds a number of leadership positions in the Society of Hospital Medicine (SHM), the largest professional organization dedicated to hospitalists and hospital quality improvement.
Jenkins is an advisor for the SHM Quality Improvement Resource Rooms.
At the annual meeting of the SHM in May 2013, Jenkins co-directed the pre-course, “QI for High Value Healthcare: Making the ABIM Foundation Choosing Wisely® Campaign a Reality.”
Jenkins was part of the UCSD team that conducted the award-winning Optimal Prevention of Hospital Acquired Venous Thromboembolism study funded by the Agency for Healthcare Research and Quality (AHRQ).
Subsequently, he headed a study of the impact of optimal venous thromboembolism prophylaxis on the rate of heparin-induced thrombocytopenia. The study was published in The Joint Commission Journal on Quality and Patient Safety in 2011. | Read study abstract
In the UCSD School of Medicine, Jenkins co-directs the “Principles to Practice” pre-internship course, a required clinical core course for fourth-year medical students. His hospital quality improvement projects for UC San Diego Health System include an effort to improve the management of alcohol withdrawal.
Jenkins received his MD degree from the University of Virginia Medical School in Charlottesville, Virginia, and did his residency training at Beth Israel Deaconess Medical Center in Boston, Massachusetts.
The 2013-2014 schedule for Medicine Grand Rounds is posted here.
Wiese is associate dean for graduate medical education and director of the Internal Medicine Residency Program at the Tulane University School of Medicine, where he is professor and associate chair of medicine in the Section of General Internal Medicine and Geriatrics.
He is Chief of Medicine, Charity and University Hospitals, Medical Center of Louisiana at New Orleans.
Among the many honors Wiese has received for his teaching:
- The Society of Hospital Medicine Excellence in Teaching Award (2005)
- The Accreditation Council for Graduate Medical Education Parker J. Palmer Courage to Teach Award (2006)
- The Association of American Medical Colleges Robert J. Glaser Distinguished Teacher Award (2006)
- The American College of Physicians Walter J. McDonald Award (2007)
- The Arnold Drapkin Memorial Award and the Leonard Tow Humanism in Medicine Award (2008)
- The Society of General Internal Medicine Mid-Career Mentorship Award (2009)
Wiese is a past president of the Society of Hospital Medicine (2010-2011). He has served as board member for the Society of Hospital Medicine, the Association of Program Directors in Internal Medicine and the Association of Subspecialty Professors.
He earned his medical degree at The Johns Hopkins School of Medicine in 1995. He did his internal medicine residency, chief residency and a medical education fellowship at the University of California, San Francisco.
About Medicine Grand Rounds
UCSD’s Medicine Grand Rounds is held weekly on Wednesday mornings, 7:30 – 8:30 a.m., in the Liebow Auditorium, second floor, Biomedical Sciences Building on the UCSD School of Medicine Campus. There is a hiatus in summer.
To see this year’s schedule and find video viewing information, visit the Medicine Grand Rounds page on the Department of Medicine website.
Virgil L. Woods, Jr., MD
1948 – 2012
“We are very saddened at the loss of our colleague and friend,” said Wolfgang Dillmann, MD, Helen M. Ranney Distinguished Professor and Chair of the Department of Medicine.
Dr. Woods was professor of medicine in Rheumatology, Allergy & Immunology.
“He was an enthusiastic clinician and teacher, and brought a high level of energy and critical thinking skills to the teaching and clinical programs in rheumatology at UCSD,” said Robert A. Terkeltaub, MD (below), professor of medicine and interim chief of the division.
“Virgil Woods was a gifted scientist, an outstanding clinician, a generous colleague, and an enthusiastic teacher,” said Mark H. Ginsberg, MD (below), colleague of Dr. Woods and a fellow rheumatologist.
“Virgil was an active and engaged rheumatologist,” he said.
“He taught his subspecialty and particularly relished working on the front lines of inpatient medicine as an academic hospitalist. In this role he assumed responsibility for acutely ill patients with a wide spectrum of conditions and was a major resource for young physicians.
“Virgil was always willing to share the clinical work load with his colleagues and was unfailingly generous in making time to teach fellows, residents, and students,” Ginsberg said.
“He was a fountain of clinical and research wisdom,” Dr. Ginsberg said, “and his untimely death is a loss to the UCSD community.”
Dr. Woods was a highly respected and productive physician-scientist. “Virgil was one of the first to use monoclonal antibodies to examine the functional role of platelet cell surface receptors,” Dr. Ginsberg said.
“In doing so, he raised some of the earliest antibodies that blocked the function of platelet integrins, antibodies that were prototypes for agents in current use in the clinic in a spectrum of diseases including multiple sclerosis and arterial thrombosis.”
In recent years, his research centered upon structural biology applications of an advanced proteomics technology.
“Virgil had a dream to use mapping of amino acids that were protected from chemical modification as a means to assess protein folding and identify sites involved in protein-protein interactions,” said Dr. Ginsberg. “With the advent of modern high-resolution protein mass spectroscopy, it was possible to analyze deuterium exchange of whole proteins as a means to study their higher order structure,” he said.
“Virgil’s singular contribution was to develop methods to proteolytically cleave proteins into peptides under conditions that prevented further deuterium exchange. This enabled him to map the accessibility of individual peptides in a folded protein, a technique called peptide amide hydrogen-deuterium exchange mass spectrometry (DXMS).”
In the following years, Dr. Woods and his colleagues refined the DXMS method, increasing its resolution and applying it in an expanding range of protein studies.
“His techniques have found wide applicability in the study of protein structures in the Structural Genomics Initiative and have been used around the world to assess protein-protein interactions,” Dr. Ginsberg said.
The work resulted in seven patents and earned considerable funding from the National Institutes of Health and other sources. Dr. Woods was the UCSD Technology Transfer Office’s Fall 2012 “Featured Pioneer.”
Dr. Woods directed the DXMS Proteomics Resource at UCSD and was actively collaborating with researchers at UCSD, The Scripps Research Institute, the Sanford-Burnham Medical Research Institute, the Salk Institute and other institutions in the United States and abroad.
“Virgil’s scientific achievements spring directly from his vision, dedication, and perseverance,” said Dr. Ginsberg. “He had a true scientific ‘green thumb.’ He could make things work when many others had tried and failed.”
Dr. Woods received his undergraduate training at UC San Francisco (BS, medical sciences) and UCSD (BA, biochemistry) and his MD degree at UC San Francisco. After interning and completing his residency at Barnes Hospital in St. Louis, Missouri, he came to UCSD as a rheumatology fellow in 1979.
He joined the Department of Medicine faculty when he completed his fellowship in 1981, and served UCSD for 31 years.
“Virgil was an outstanding colleague and faculty member by being an exceptional clinician, enthusiastic teacher and highly creative scientist,” said Dr. Dillmann.
Dr. Woods is survived by his wife, Betsy, and three children; his parents; and three brothers.
Profile of Dr. Woods
UCSD Press Releases About His Work
- LICR/UCSD Team Solves Mystery of Centromeres, the Genetic Machinery for Proper Cell Division >
- New Drug Developed at UC-San Diego Has Potential to Treat Hypertension and Heart Disease >
- Powerful Approach to the Analysis of Protein Motions >
- Vital Protein Complex and Therapeutic Possibilities Revealed >
On July 19, Dr. Ken Kaushansky officially begins his work as Senior Vice President for Health Sciences and Dean of the School of Medicine at Stony Brook University in New York.
When he announced his departure to the faculty and staff of the UCSD Department of Medicine on June 7, he described his new position as an opportunity to implement, on a larger scale, the successful programs that the Department of Medicine has instituted under his leadership here.
He called his years at UCSD a time of “incredible transition in our faculty, our leaders, our teaching programs, and our clinical impact.”
During Dr. Kaushansky’s tenure as Helen M. Ranney Distinguished Professor and Chair, the Department of Medicine expanded from 253 to over 420 faculty members, added four divisions, and recruited 11 division chiefs. Its annual budget grew from $86 million to nearly $150 million.
“Dr. Kaushansky has been an outstanding Chair for this department,” said Dr. Robert “Chip” Schooley, Professor and Chief of the Division of Infectious Diseases and Vice Chair for Academic Affairs in the Department of Medicine.“
During his eight years as Chair, the medical house staff program became one of the most highly regarded programs in the country. New divisions in Hospital Medicine, Biomedical Informatics, Geriatrics, and Global Public Health were developed and research programs thrived throughout the Department,” Dr. Schooley said.
“In response to increasing interest in international medicine among the medical house staff, Dr. Kaushansky launched the Department’s Global Medicine Residency Program in 2009,” he said.“Dr. Kaushansky worked with his counterpart at the Universidade Eduardo Mondlane to establish a model program in international cooperation that has revitalized postgraduate medical training in the Republic of Mozambique.”
Since 2002, the Department’s NIH research funding has grown from $60 million to $113.6 million. It has more than twice as many complex multi-investigator program-project grants and career development awards granted to the junior faculty and fellows.
The Department has also boosted its showing in the “America’s Best Hospitals” rankings from U.S.News & World Report. In 2002, two subspecialty clinical programs ranked in the nation’s top 50: respiratory at 9th and cancer at 41st. In the most recent rankings, five subspecialties ranked in the top 50, including one (HIV/AIDS) in the top 10.
“Ken was directly responsible for building up the strength of clinical care at UCSD,” said Dr. Greg Maynard (right), Health Sciences Professor of Medicine and Chief of the Division of Hospital Medicine.
“He recruited me here about 7-1/2 years ago, and in that time, the Hospital Medicine program has grown from 4 hospitalists to nearly 30, as just one example of that.”
“As a product of the Physician-Scientist Training Program,” she said, “I am one of those few who enjoyed special access to this busy department chair. His doors were always open. I recall having multiple consultations with him at various stages of my career as it grew here at UCSD.
“When the time came for me to choose where to spend the first decade of my young career as an independent investigator, it was his support and a match in our visions which tilted my decision in favor of UCSD,” she said.
“His tireless efforts at instilling the physician-scientist culture here in the Department of Medicine, both from top-down and bottom-up, have paved the path for many young folks like me to craft a career for themselves as physician-scientists,” Dr. Ghosh said.
“Ken was the reason why I eventually accepted the GI Chief job at UCSD,” said Dr. John M. Carethers (right), now John G. Searle Professor and Chair of the Department of Internal Medicine at the University of Michigan.
When Dr. Kaushansky joined the UCSD faculty, Dr. Carethers was an associate professor of medicine in the Division of Gastroenterology. Dr. Carethers became division chief in 2004
“Ken … gave me enough autonomy to help grow the GI Division, gain a GI Center grant, coordinate well with the Cancer Center and other divisions, and allowed me to grow personally,” Dr. Carethers said. “The GI Division flourished under that mantra.
“We went to a clinical service chief structure, developed a new hierarchy for our administrative staff, started a robust web site, grew our fellowship, and survived many challenges over that time because of his support,” he said.
“Ken provided invaluable advice on my career,” Dr. Carethers said. “He was a great sounding board, not pretentious; encouraging, but never overprotective. I think he understood the value of growth and opportunity, something that is hard to come by these days.”
“He is accessible 24/7 to offer support and guidance, which is huge to a new faculty member just moving cross country,” she said.
“On a personal note, when I had barely arrived here he was already nominating me for positions and committees to help me advance my career.”
“His integrity, fairness, and open-mindedness built an environment of trust that allowed the substantial growth of the Department of Medicine during his tenure as Chair,” said Dr. Kirk U. Knowlton (right), Professor of Medicine and Chief of the Division of Cardiology.
“I am struck by how he has been able to hold the respect of so many people with widely disparate interests,” Dr. Knowlton said.
“This included people who were fully engaged in basic science and those who were busy taking excellent care of their patients; medical students and residents and post-graduate research fellows; administrators and faculty; and others over whom he might have had influence or who crossed his path.
“The people he has worked with knew that they could count on him to represent their interests in the context of the institution’s goals in a considered and reasonable manner while at the same time maintaining his vision of the future of the Department of Medicine.”
“He is a rare breed,” Dr. Maynard said. “I guess I’d call him a quadruple threat. An outstanding scientist, a superb clinician, a great educator, and an incredible leader and administrator to boot.
“While he is not really replaceable,” he said, “he has left an enduring legacy that stresses clinical and operational excellence, as well as research contributions.”
Dr. Finn said, “In addition to [his] world-class scientific reputation, Dr. Kaushansky is most respected for his character and vision.”
“He makes his department and faculty a priority, while striving to always do the right thing for the patients,” she said. “He will be most remembered for his infectious enthusiasm, upbeat attitude, and steady, insightful guidance of students and faculty.”
“He leaves an 8-year legacy that advanced the Department of Medicine in many ways,” said Dr. Carethers, “including growing faculty, changing the way residents learn, obtaining key recruitments for division chiefs and faculty, enhancing VA relations, and being an all out cheerleader for the Department.”
On June 21, Dr. Kaushansky was honored at a farewell reception hosted by David Brenner, M.D., Dean of the UCSD School of Medicine and Vice Chancellor, Health Sciences. In his remarks there, Dr. Kaushansky expressed his appreciation for “eight and a half years of good friends, challenges, and teamwork.”
Observing that he had been involved in recruiting many of the faculty members in the room, he said, “Everything at UCSD works toward recruiting great people.”
“It’s easy, at UCSD, to build things and to make a difference,” he said. “Everybody makes everyone else stronger.”
Dr. Kaushansky praised UCSD’s “incredible richness” of people, science, teaching, and clinical programs. “I’ve never seen more devotion to the three missions,” he said.
And now he looks ahead.
“In academic medicine, you get to re-craft yourself every ten years,” he said. “I’m looking forward to my newly-found steep learning curve.”
Dr. Kaushansky was honored at a tribute from the senior leaders of the Department of Medicine on July 11. There will be a tribute from all departmental staff, faculty, and house staff on a date to be selected.
“Although one could cite metric after metric by which his unceasing efforts strengthened the Department,” said Dr. Schooley, “what many of us think distinguished his tenure most was the way in which his ‘bottom up’ style of leadership brought out the best in all of us.
“The Department will benefit for many years to come from things he set in motion – as will each of its members from what we learned from his multifaceted demonstration of scholarship, integrity, imagination and dedication to his Department.”
Dr. Greg Maynard and the UCSD Hospitalist Program are featured in the story, “Prevention Prowess: 3 hospitals recognized for VTE prevention innovations,” in The Hospitalist.
Gregory A. Maynard, MD, MSc, is Health Sciences Professor and Chief of the Division of Hospital Medicine.
The honor was announced in November. It recognizes Dr. Maynard’s outstanding contributions in improving the quality of hospital care and mentoring hospitalists in the U.S. and abroad.
Dr. Maynard has led the UCSD hospitalist team in developing nationally-recognized patient safety and quality improvement programs.
These efforts have advanced two crucial aspects of patient safety in the hospital: venous thromboembolism prevention and glycemic control.
Dr. Maynard is also an active mentor in the developing field of hospital medicine.
He’s advising a number of institutions as they develop hospital medicine programs. Among these is the Pontificia Catholic University of Chile in Santiago, where Dr. Maynard helped conduct the first-ever Chilean hospitalist meeting last November.
Dr. Maynard and the other “Top Hospitalist” honorees are profiled in the November 2008 issue of ACP Hospitalist. | Read the article
UCSD’s advances in patient care quality improvement
Gregory A. Maynard, M.D., M.Sc., joined the UCSD faculty in 2003 as head of the new Hospital Medicine division.
Since then, the division has expanded to 23 faculty members and has won national awards for its achievements in hospital care quality improvement.
The program was developed with funding from the Agency for Healthcare Research and Quality.
Dr. Maynard and his colleagues developed a risk assessment tool that allows healthcare professionals to identify quickly and accurately the most appropriate venous thromboembolism prevention measures for each hospitalized patient.
As a result, the UCSD Medical Center is among the leaders in the U.S. in preventing venous thromboembolism in its inpatients.
At the UCSD Medical Center in Hillcrest alone, the program prevents approximately 50 cases of venous thromboembolism each year.
The tool, now part of the Venous Thromboembolism Resource Room on the Society of Hospital Medicine website, is now in use at medical centers around the nation.
UCSD’s hospitalists also play a major part in the Society of Hospital Medicine’s Inpatient Glycemic Control Task Force, which is headed by Dr. Maynard.
The work of the task force was presented recently in a special supplement issue of the Journal of Hospital Medicine (JHM).
“Most of the work on the SHM website, this supplement, and the SHM QI pre-courses features contributions and lessons learned from the hospitalists at UCSD,” Dr. Maynard said.
The term “hospitalist” was first used in 1996 in a New England Journal of Medicine article that highlighted the importance of inpatient-focused care in healthcare today. | Read the article
The role of the hospitalist
In creating the “Top Hospitalists” list, the American College of Physicians is recognizing the increasing importance of the new specialty of hospital medicine.
Hospitalists dedicate themselves to improving the quality of care for hospitalized patients. Their efforts range from creating new disease management protocols to revamping hospital information systems.
According to the Society of Hospital Medicine, there are an estimated 20,000 hospitalists in practice today.
As experienced attending physicians who are continuously available on the wards, hospitalists also play a central role in training students, residents, and fellows.
- About Dr. Maynard and the UCSD hospitalists
- UCSD hospitalists’ quality improvement efforts
- Current quality improvement projects
- Quality improvement news from UCSD’s hospitalists
- Recent publications in quality improvement from Hospital Medicine at UCSD
- Glycemic Control Task Force, Society of Hospital Medicine
- Special supplement issue of the Journal of Hospital Medicine (JHM) on glycemic control
- Venous thromboembolism prevention program
- Venous thromboembolism risk assessment tool
- About hospitalists
- Other links
Pulmonary specialist Dr. Timothy Morris, infectious disease physician-scientist Dr. Davey M. Smith, and the Division of Hospital Medicine were honored August 21 as “Health Care Champion” finalists.In all, 5 individuals and teams from UCSD Medical Center received a Champion award and 20 were selected as finalists.
These include a venous thromboembolism (VTE) prevention program that has made the UCSD hospitals a national leader in protecting inpatients from the risk of developing blood clots.
The program was developed as a joint venture between Dr. Maynard and the Hospitalist Program and Dr. Timothy Morris. A clinical and research specialist in VTE, Dr. Morris helped create the VTE prevention protocols and oversees the follow-up on individual cases.
Dr. Morris, left, is Professor of Medicine and Clinical Service Chief in the Division of Pulmonary and Critical Care Medicine. He is medical director for both the Respiratory Care program and the Pulmonary Function Laboratory.
In July, the California Thoracic Society honored Dr. Morris with the Outstanding Clinician Award for 2008.
The Pulmonary and Critical Care Medicine division was recognized by U.S. News & World Report in 2008 for the 14th consecutive year as one of the top ten centers in the nation, and #1 in California, for the treatment of respiratory diseases.
Davey M. Smith, M.D., M.A.S., Assistant Adjunct Professor of Medicine, is a physician-scientist in the Division of Infectious Diseases. Dr. Smith is medical director of the Early Intervention Program at the Antiviral Research Center. A translational research virologist, he specializes in the study of HIV transmission.
Earlier this year, Dr. Smith (left) received an R01 grant award from the National Institute of Mental Health for a 5-year, multi-national study of HIV and the brain.
Dr. Smith directs the Center for AIDS Research Viral Pathogenesis Core on the UCSD campus.
- Dr. Timothy Morris
- Dr. Davey M. Smith
- Division of Hospital Medicine
- Health Sciences Communications stories
The American Society of Health-System Pharmacists (ASHP) Research and Education Foundation has awarded one of its two 2008 Hospital Pharmacist-Hospitalist Collaboration Research Grants to the UCSD Division of Hospital Medicine and the Department of Pharmacy.Hospitalist Gregory Maynard, M.D., M.Sc., and pharmacist Kevin W. Box, Pharm.D., are the principal investigators.
“With the help of other team members, we expect to achieve meaningful improvement”
Dr. Maynard is Chief of the Division of Hospital Medicine and a nationally recognized leader in quality improvement and patient safety.
“It definitely takes a multidisciplinary team to create a design change in health care delivery and then carry it out successfully,” Dr. Maynard says.
“We are fortunate that the hospitalists and pharmacists work so well together.
“With the help of other team members, we expect to achieve meaningful improvement with this transition from insulin infusion, just as we have with other related projects.”
UCSD’s project will test a multidisciplinary model for managing diabetic inpatients’ blood glucose levels in the first 48 hours after an insulin infusion.
The goal is to find an effective team protocol that can be adapted easily for use in other areas.
Other quality improvement projects: success in VTE prevention
UCSD’s hospitalists are involved in several patient care quality improvement projects. These include an ongoing venous thromboembolism (VTE) prevention program that has set a national benchmark for patient safety.
About the ASHP grant program
The ASHP Research and Education Foundation is a nonprofit organization devoted to improving patients’ health and well-being through the appropriate, safe and effective use of medications.
The Foundation’s Hospital Pharmacist-Hospitalist Collaboration Research Grant Program supports innovative projects for improving patient care in hospitals and health systems.
This year, applicants were invited to submit proposals for improving glycemic control in hospitalized patients. The UCSD project won the grant in a highly competitive field.
Hospitalist-Pharmacy team awarded ASHP grant in 2007 as well
This is UCSD’s second consecutive year as an ASHP grant award winner.
Last year, the Division of Hospital Medicine and the Department of Pharmacy received the award for its “Hospitalist and Pharmacist VTE Treatment Protocol Collaborative.”
In that project, Dr. Maynard was Hospitalist Investigator and Dr. Robert Weibert, Pharm.D., was Pharmacist Investigator.
Hospitalists Weijen Chang, M.D. (below), and Joel Trambley, M.D., Ph.D., have received the 2008 Medicine 401 “Excellence in Teaching” award for their outstanding contributions to the core clerkship course.
They were honored at the annual Medicine 401 Faculty and Resident Appreciation Reception on June 4, 2008.
Dr. Chang, Assistant Clinical Professor of Medicine in the Division of Hospital Medicine, specializes in pediatrics and hospital medicine. He provides hospitalist inpatient services at Thornton Hospital and UC San Diego Medical Center Hillcrest and is a pediatric hospitalist at Rady Children’s Hospital.
Dr. Chang completed his residency training in Internal Medicine/Pediatrics at Duke University in Durham, NC. Formerly Director of the Division of Hospital Medicine at Dartmouth-Hitchcock Medical Center in Manchester, NH, he joined the UC San Diego Hospital Medicine staff in October, 2007.
Dr. Trambley is Assistant Clinical Professor of Medicine in the Division of Hospital Medicine. He joined UC San Diego from the Physician Foundation at California Pacific Medical Center, where he was a hospitalist with the Liver Disease Management and Transplantation Program.